Drug Discovery World

APRIL 4, 2024

It will take place on 2 May at 3pm BST, 10am EDT, 4pm CEST and will presented by Ron Morena, Manager in Analytical Bioassay at Tanvex Biopharma CDMO, along with and Dr Neha Mishra, Senior Scientist in the BioProduction R&D team, Revvity. Characterizing binding properties of complex biomolecules is a critical step.

Bioassay 52

Bioassay Antibody Drug Delivery Scientist 52

Drug Discovery World

APRIL 25, 2024

It will take place on 2 May at 3pm BST, 10am EDT, 4pm CEST and will be presented by Ron Morena, Manager in Analytical Bioassay at Tanvex Biopharma CDMO, along with and Dr Neha Mishra, Senior Scientist in the BioProduction R&D team, Revvity. Characterizing binding properties of complex biomolecules is a critical step.

Development 52

Development Bioassay Antibody Drug Delivery 52

Drug Discovery World

NOVEMBER 30, 2023

They are called: Stanford researchers construct the most complete synthetic microbiome , Highs and lows of drug repurposing , and Unlocking the potential of mucoadhesive drug delivery.

Drugs 52

Drugs Drug Delivery Scientist Development 52

Drug Discovery World

APRIL 18, 2024

It will take place on 2 May at 3pm BST, 10am EDT, 4pm CEST and will be presented by Ron Morena, Manager in Analytical Bioassay at Tanvex Biopharma CDMO, along with and Dr Neha Mishra, Senior Scientist in the BioProduction R&D team, Revvity. Characterizing binding properties of complex biomolecules is a critical step.

Development 52

Development Bioassay Antibody Drug Delivery 52

Scienmag

MAY 25, 2021

– Before the huge potential of tiny nanocarriers for highly targeted drug delivery and environmental clean-up can be realized, scientists first need to be able to see them. Credit: Washington State University PULLMAN, Wash.

Medicine 52

Medicine Drug Delivery Scientist Drugs 52

Scienmag

DECEMBER 2, 2020

– Scientists used human white blood cell membranes to carry two drugs, an antibiotic and an anti-inflammatory, directly to infected lungs in mice. The nano-sized drug delivery method developed at Washington State University successfully treated both the bacterial growth and inflammation in the mice’s lungs.

Medicine 51

Medicine Drug Delivery Scientist Drugs 51

pharmaphorum

OCTOBER 12, 2022

Sustainability for Injectable Delivery Devices. Connected Drug Delivery Devices. Kim Kristiansen, Principal Scientist, LEO Pharma A/S. Kevin Kusmierek, Scientist, Primary Packaging and Medical Devices, CSL Behring. Carsten Worsoe, Principal Scientist, Novo Nordisk. Primary Packaging Development.

Drugs 52

Drugs Packaging Packaging Drug Delivery 52

Drug Discovery World

APRIL 10, 2024

It will take place on 2 May at 3pm BST, 10am EDT, 4pm CEST and will be presented by Ron Morena, Manager in Analytical Bioassay at Tanvex Biopharma CDMO, along with and Dr Neha Mishra, Senior Scientist in the BioProduction R&D team, Revvity. Characterizing binding properties of complex biomolecules is a critical step.

Development 40

Development Bioassay Antibody Drug Delivery 40

Scienmag

JANUARY 22, 2021

Scientists successfully tested innovative drug delivery system developed by ILIAS Biologics, Inc.

Drug Delivery Systems 42

Drug Delivery Systems Drug Delivery Scientist Medicine 42

Roots Analysis

MAY 21, 2024

In addition, NLCs offer benefits such as high drug loading capacity, improved drug retention and avoidance of drug expulsion. Advantages of Lipid Nanoparticle LNPs are gaining significant attention of formulation scientists in drug delivery due to the various advantages offered by them.

Drug Delivery 40

Drug Delivery Drugs Gene Therapy Bioavailability 40

Pharmaceutical Technology

SEPTEMBER 8, 2022

Pharmaceutical solid dosage forms are the most popular in the pharmaceutical industry and are one of the most used drug delivery methods across patient groups. Pharmaceutical solid dose manufacturing companies in contract marketing segment have gained a vital position in pharmaceutical formulations.

Manufacturing 100

Manufacturing Marketing Contract Manufacturing Containment 100

pharmaphorum

OCTOBER 18, 2021

Chair for 2022: Heinrich Haas, VP RNA Formulation and Drug Delivery, BioNTech. Featured speakers: •Jimmy Weterings, Principal Scientist Oligonucleotide Chemistry, AstraZeneca. Who should attend: •Research & Development Directors/Managers/Scientists. Head of RNA Formulation and Drug Delivery.

RNA 52

RNA Drug Delivery Scientist Clinical Development 52

pharmaphorum

APRIL 29, 2021

Uncover advances in CNS gene therapy , new generation vectors for intravenous delivery, and the challenges of scaling up for CNS delivery beyond highly specialized centers. The high concentration of scientists who face similar challenges makes this Summit so essential to the development of the field.

Drug Delivery 52

Drug Delivery Gene Therapy In-Vivo Antibody 52

pharmaphorum

NOVEMBER 17, 2021

The Future of Drug Delivery and Combination Product Device Design. The pre-filled syringes industry is growing at an exponential rate with innovations in parenteral delivery device development to aid self-administration and deliver biologics, high concentration, and large-volume drug products.

Drugs 52

Drugs Drug Delivery Engineer Production 52

pharmaphorum

JANUARY 18, 2022

Christine lynn lanning, Distinguished Scientist, Device Area Leader, Merck. Deep S Bhattacharya, Senior Scientist, Drug Product Development and Design, Pfizer. Engage in panel discussions with industry leaders to navigate the accelerating digital health landscape for combination products and drug delivery systems.

Drug Delivery 52

Drug Delivery Production Drug Delivery Systems Packaging 52

Drug Discovery World

AUGUST 11, 2022

The project will see MDC and ZEISS produce a live cell imaging and image analysis pipeline that can be deployed to assess novel drug delivery technologies and therapeutics, enabling innovators to advance their projects. . Official comments .

Drugs 52

Drugs Drug Delivery Medicine Development 52

Drug Discovery World

JANUARY 17, 2023

Oregon State University College of Pharmacy scientists have shown that lipid nanoparticles and messenger RNA could treat blindness associated with a rare genetic condition. . Researchers developed nanoparticles able to penetrate the neural retina and deliver mRNA to the photoreceptor cells whose proper function makes vision possible. .

Gene Editing 98

Gene Editing Gene Gene Therapy Genetics 98

XTalks

JANUARY 18, 2023

Hear more about the new subvariant and why scientists are keeping a close eye on it. Ayesha also talked about the FDA approval of AstraZeneca’s asthma inhaler Airsupra, the first-in-class drug that contains both a beta agonist and corticosteroid. has been found in dozens of other countries now, cases remain low around the world.

Life Science 52

Life Science FDA Approval Containment Scientist 52

pharmaphorum

OCTOBER 6, 2022

Its application being in medicine and drug delivery, she explained that her work permits scientists to do “chemistry inside the human body, to make sure drugs go to the right place and stay away from the wrong place”. . — The Nobel Prize (@NobelPrize) October 5, 2022.

Drug Delivery 52

Drug Delivery DNA Medicine Research 52

The Pharma Data

JANUARY 17, 2021

Evox uses its proprietary DeliverEX technology to modify exosomes using various molecular engineering, drug loading, and targeting strategies to facilitate targeted drug delivery to organs of interest, including the brain and the central nervous system.

Life Science 40

Life Science Drug Delivery Engineer Drugs 40

Drug Discovery World

NOVEMBER 17, 2022

Its strategy is based on identifying, selecting, and nurturing high-quality European science and this model aims to bring together scientists from across Europe, combining tools and expertise from academia and industry. . This could have significant implications for our understanding of biology, in treating illness and in drug delivery.

Bacteria 52

Bacteria Engineer Gene Genetics 52

The Pharma Data

OCTOBER 14, 2020

15, 2020 /PRNewswire/ — Seattle Gummy Company’s breakthrough gummy drug program, which delivers Active Pharmaceutical Ingredients (APIs) in its innovative gummy matrix, recently won its first Investigational New Drug Application (IND) approval from FDA on the company’s allergy gummy medication, designated as IND 140312.

Drugs 52

Drugs Allergies Cardiology Drug Delivery 52

pharmaphorum

JUNE 30, 2021

Scientists at Oxford University in the UK are also working on a nasally-delivered COVID-19 vaccine, while a team at Imperial College London is also testing whether its own saRNA-based shot and the AstraZeneca/Oxford vaccine can be effective when delivered by inhalation.

Vaccination 98

Vaccination Vaccine Trials Immune Response 98

Cloudbyz

MAY 15, 2023

For instance, if the trial involves a novel drug-delivery system, the DSMB might include a pharmaceutical scientist. Sometimes, it also includes experts in other relevant disciplines depending on the trial’s requirements.

Clinical Trials 73

Clinical Trials Clinical Trials Trials Drug Delivery Systems 73

The Pharma Data

APRIL 8, 2021

The Company will share a Spotlight Theater Presentation: The Orchestrated Immune Response: Dynamic Forces Guiding Cancer Immunity , introducing a novel framework for understanding the role of the immune system in cancer, with the potential to reshape the way scientists develop medicines to counteract tumour growth.

DNA 52

DNA Medicine Genome Genomics 52

Drug Discovery World

AUGUST 3, 2022

In a recent publication from scientists at the University of Bordeaux, a CPP-based nanoparticles approach was reportedly used to deliver siRNA into cancer cells of solid tumours. In a second publication by the scientists at Bordeaux, CPP-based nanoparticles were applied as a vector for an anti-miRNA (AMO).

Bioavailability 52

Bioavailability In-Vivo RNA In-Vitro 52

XTalks

OCTOBER 1, 2020

Leaving academia for industry is a route that academic scientists and professors did not traditionally pursue in the past due to perceived differences in skillsets, experiences and even associated stigmas. WeiQi Lin, MD, PhD, executive vice president of research & development and principal scientist, DURECT Corporation.

Scientist 52

Scientist In-Vitro Research Life Science 52

Drug Discovery World

APRIL 3, 2023

As a business of scientists, we remain passionate about the exciting developments in the industry, from research to precision therapies, and insatiably curious about the new possibilities that can be achieved by overcoming the limits of standard research tools and methods. To what do you attribute your success?

Antibody 52

Antibody Gene Therapy Gene In-Vitro 52

XTalks

FEBRUARY 24, 2021

Type 1 diabetes is not like other chronic conditions such as hypertension or hyperlipidemia, which people can start to manage early given risk factors like family history and weight, and that can be managed much more effectively with drugs and advances in drug delivery. “We

Insulin 64

Insulin Production Drug Delivery Marketing 64

Delveinsight

FEBRUARY 25, 2021

Beam adds to drug delivery stable with USD 120 Million GuideTx buy. Human brain organoids are developed using induced pluripotent stem cells, aka iPS cells derived from skin or blood cells, which have been reprogrammed back to an embryonic stem cell-like state, enabling scientists to develop any cell type.

DNA 52

DNA In-Vivo Genetics Medicine 52

XTalks

MAY 30, 2023

Behfar, senior scientist at VTT, in the news release. Aayush Jaiswal, research scientist at VTT said, “Ours is the first nanocellulose-based ECG patch with no plastic additives. Bio-based substrates like cellulose e-skin are promising alternatives to fossil-based ones.

Drug Delivery 98

Drug Delivery Drug Delivery Systems Manufacturing Contamination 98

Drug Discovery World

NOVEMBER 8, 2023

Sebastian Jaeger, PhD, Senior Scientist, ADCs & Targeted NBE Therapeutics, Merck Healthcare KGaA, on: ‘Evaluation of Fcab-drug conjugates as a novel antibody-based format for targeted drug delivery’.

Antibody 64

Antibody Engineer Protein Scientist 64

Drug Discovery World

JANUARY 17, 2024

Schreiber said: “Arena’s single source of funding frees our scientists from the typical short-term cycles of grant and venture capital funding. Our aim is to accelerate progression from deep mechanistic human biology to biotech-enabled drug development.”

Drugs 52

Drugs Drug Delivery Life Science Gene 52

Drug Discovery World

NOVEMBER 9, 2023

Gail Calvert, Field Application Scientist, Sartorius UK, on: ‘Leveraging integrated and advanced technologies for successful cell line development’. Jorge Dias, PhD, Principal Scientist, Alchemab Therapeutics, on: ‘A patient-first approach to discover first-in-class antibody therapeutics’.

Engineer 52

Engineer Antibody Protein In-Vivo 52

Camargo

OCTOBER 14, 2020

Approval of the Month: FDA Approves First Closed-Loop Monitoring and Drug Delivery Device. The FDA has announced its approval of a bluetooth-controlled insulin delivery and monitoring system for use in pediatric patients ages 2 through 6 with Type 1 diabetes. Regulatory Scientist. Co-Authors: Ken Phelps.

Development 196

Development Insulin Drug Delivery Production 196

XTalks

JULY 28, 2020

For decades, formulation scientists have relied on the assumption that common pharmaceutical excipients are biologically inert. For example, Advil tablets contain 18 inactive ingredients alongside ibuprofen, the drug’s active pharmaceutical ingredient (API).

Protein 103

Protein Drugs In-Vitro Scientist 103

Drug Discovery World

NOVEMBER 15, 2023

to a vibrant international network of talented scientists, entrepreneurs and educators. MT: What industry-wide drug discovery breakthrough has had the most impact on your research? MT: What industry-wide drug discovery breakthrough has had the most impact on your research? This has been a central tenet throughout my career.

Research 59

Research Engineer Drug Delivery Scientist 59